​

Arcutis Biotherapeutics (ARQT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Arcutis Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$59.61M

Latest Revenue (Q)

$30.86M

Main Segment (Y)

Other Revenue

Arcutis Biotherapeutics Revenue by Period

Arcutis Biotherapeutics Revenue by Year

DateRevenueChange
2023-12-31$59.61M1517.09%
2022-12-31$3.69M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Arcutis Biotherapeutics generated $59.61M in revenue during NA 2023, up 1517.09% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Arcutis Biotherapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$30.86M-37.75%
2024-03-31$49.57M266.47%
2023-12-31$13.53M-64.51%
2023-09-30$38.11M634.28%
2023-06-30$5.19M86.62%
2023-03-31$2.78M-6.08%
2022-12-31$2.96M308.41%
2022-09-30$725.00K100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Arcutis Biotherapeutics generated $30.86M in revenue during Q2 2024, up -37.75% compared to the previous quarter, and up 1109.60% compared to the same period a year ago.

Arcutis Biotherapeutics Revenue Breakdown

Arcutis Biotherapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Product$29.19M$3.69M
Other Revenue$30.42M-

Arcutis Biotherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other Revenue (51.04%), and Product (48.96%).

Quarterly Revenue by Product

Product/ServiceDec 23Sep 23Dec 22Sep 22
Other Revenue$420.00K$30.00M--
Product$21.08M$8.11M$2.96M$725.00K

Arcutis Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Product (98.05%), and Other Revenue (1.95%).

Arcutis Biotherapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

CountryDec 22Sep 22
Product$2.96M$725.00K

Arcutis Biotherapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Product (100.00%).

Arcutis Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
APLSApellis Pharmaceuticals$366.28M$176.57M
CHRSCoherus BioSciences$257.24M$70.77M
MIRMMirum Pharmaceuticals$186.37M$77.88M
SPROSpero Therapeutics$96.73M$13.47M
ARQTArcutis Biotherapeutics$59.61M$30.86M
BOLTBolt Biotherapeutics$7.88M$1.14M
DSGNDesign Therapeutics--
XFORX4 Pharmaceuticals-$560.00K
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
ERASErasca--
GLUEMonte Rosa Therapeutics-$4.70M

ARQT Revenue FAQ

What is Arcutis Biotherapeutics’s yearly revenue?

Arcutis Biotherapeutics's yearly revenue for 2023 was $59.61M, representing an increase of 1517.09% compared to 2022. The company's yearly revenue for 2022 was $3.69M, representing an increase of 100.00% compared to 2021. ARQT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Arcutis Biotherapeutics’s quarterly revenue?

Arcutis Biotherapeutics's quarterly revenue for Q2 2024 was $30.86M, a -37.75% decrease from the previous quarter (Q1 2024), and a 494.57% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $49.57M, a 266.47% increase from the previous quarter (Q4 2023), and a 1682.42% increase year-over-year (Q1 2023). ARQT's quarterly revenue for Q4 2023 was $13.53M, a -64.51% decrease from the previous quarter (Q3 2023), and a 356.81% increase year-over-year (Q4 2022).

What is Arcutis Biotherapeutics’s revenue growth rate?

Arcutis Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

What are Arcutis Biotherapeutics’s revenue streams?

Arcutis Biotherapeutics's revenue streams in c 23 are Product, and Other Revenue. Product generated $29.19M in revenue, accounting 48.96% of the company's total revenue, up 691.81% year-over-year. Other Revenue generated $30.42M in revenue, accounting 51.04% of the company's total revenue

What is Arcutis Biotherapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Arcutis Biotherapeutics was Other Revenue. This segment made a revenue of $30.42M, representing 51.04% of the company's total revenue.